| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972971 | The Journal of Heart and Lung Transplantation | 2006 | 8 Pages |
Abstract
A lifetime model based on current UK practice demonstrates that BTT VAD patients had significant quality-adjusted life-years, but treatment was expensive when compared with the worst clinical scenario. If device technology improves, costs are reduced, or referral practice changes, results should be re-assessed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Linda D. PhD, Matthew MSc, Fay MMath, Nikolaos PhD, Carol MPhil, Nicholas R. FRCP, Stephen R. FRCP, FRCS, Steven MD, FRCS, Noreen BA, Martin BA,